Patent directory · USPTO A61K / A61P
Patents matching “REGENERON PHARMACEUTICALS, INC.”
837 pharma patents match "REGENERON PHARMACEUTICALS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 837 pharmaceutical patents matching "REGENERON PHARMACEUTICALS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10106616
Antagonist antibodies to human prolactin receptor (PRLR)
granted -
US 10106610
Antibodies comprising chimeric constant domains
granted -
US 10081670
Human antibodies to Ebola virus glycoprotein
granted -
US 10076571
Methods for reducing lipoprotein(a) levels by administering an inhibitor of proprotein convertase subtilisin kexin-9 (PCSK9)
granted -
US 10077311
Human antibodies to GFR alpha3 and methods of reducing pain associated with GFR alpha3-related diseases
granted -
US 10070632
Rodents having a humanized TMPRSS gene
granted -
US 10070631
Rodents having a humanized TMPRSS gene
granted -
US 10072076
Human antibodies to NAv1.7
granted -
US 10072086
Stabilized formulations containing anti-interleukin-6 receptor (IL-6R) antibodies
granted -
US 10066017
Methods for treating chronic sinusitis with nasal polyps by administering an IL-4R antagonist
granted -
US 10059771
Methods for treating nasal polyposis by administering an IL-4R antagonist
granted -
US 10047152
Human antibodies to fel D1 and methods of use thereof
granted -
US 10047153
Human antibodies to Fel d1 and methods of use thereof
granted -
US 10047160
Anti-EGFRvIII antibodies and uses thereof
granted -
US 10023644
Antigen-binding proteins that activate the leptin receptor
granted -
US 10023641
Anti-TIE2 antibodies and uses thereof
granted -
US 10023642
Anti-PDGFR-beta antibodies and uses thereof
granted -
US 10023916
Markers of tumor cell response to anti-cancer therapy
granted -
US 10023654
Anti-PCSK9 antibodies
granted -
US 10015953
Non-human animals having a humanized cluster of differentiation 47 gene
granted -
US 10011647
IL-33 antagonists and uses thereof
granted -
US 10005834
Biomarkers related to interleukin-33 (IL-33)-mediated diseases and uses thereof
granted -
US 10000564
Methods of treating an inflammatory condition or sensitivity to an allergen with anti-IL-33 antibodies
granted -
US 9986724
Genetically modified non-human animals and methods of use thereof
granted